These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 32168416)
1. Oridonin inhibits the migration and epithelial-to-mesenchymal transition of small cell lung cancer cells by suppressing FAK-ERK1/2 signalling pathway. Xu L; Bi Y; Xu Y; Zhang Z; Xu W; Zhang S; Chen J J Cell Mol Med; 2020 Apr; 24(8):4480-4493. PubMed ID: 32168416 [TBL] [Abstract][Full Text] [Related]
2. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer. Chen K; Ye J; Qi L; Liao Y; Li R; Song S; Zhou C; Feng R; Zhai W Anticancer Drugs; 2019 Oct; 30(9):925-932. PubMed ID: 31517732 [TBL] [Abstract][Full Text] [Related]
3. Oridonin inhibits epithelial-mesenchymal transition of human nasopharyngeal carcinoma cells by negatively regulating AKT/STAT3 signaling pathway. Liu W; Huang G; Yang Y; Gao R; Zhang S; Kou B Int J Med Sci; 2021; 18(1):81-87. PubMed ID: 33390776 [TBL] [Abstract][Full Text] [Related]
4. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells. Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515 [TBL] [Abstract][Full Text] [Related]
5. Suppression of PERK/eIF2α/CHOP pathway enhances oridonin-induced apoptosis by inhibiting autophagy in Small-Cell lung cancer cells. Xu L; Jiang Y; Bi Y; Zheng S; Wu Y; Wu Y; Xu Y; Chen J Biomed Pharmacother; 2024 Jun; 175():116684. PubMed ID: 38713951 [TBL] [Abstract][Full Text] [Related]
6. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma. Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells. Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060 [TBL] [Abstract][Full Text] [Related]
8. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways. Jiang JH; Pi J; Jin H; Cai JY J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997 [TBL] [Abstract][Full Text] [Related]
9. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling. Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296 [TBL] [Abstract][Full Text] [Related]
10. Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells. Hsieh YS; Chu SC; Hsu LS; Chen KS; Lai MT; Yeh CH; Chen PN Food Chem Toxicol; 2013 Dec; 62():908-18. PubMed ID: 24161487 [TBL] [Abstract][Full Text] [Related]
11. Batatasin III Inhibits Migration of Human Lung Cancer Cells by Suppressing Epithelial to Mesenchymal Transition and FAK-AKT Signals. Pinkhien T; Petpiroon N; Sritularak B; Chanvorachote P Anticancer Res; 2017 Nov; 37(11):6281-6289. PubMed ID: 29061811 [TBL] [Abstract][Full Text] [Related]
12. Oridonin Suppresses Proliferation of Human Ovarian Cancer Cells via Blockage of mTOR Signaling. Xia R; Chen SX; Qin Q; Chen Y; Zhang WW; Zhu RR; Deng AM Asian Pac J Cancer Prev; 2016; 17(2):667-71. PubMed ID: 26925661 [TBL] [Abstract][Full Text] [Related]
13. Oridonin inhibits tumor growth in glioma by inducing cell cycle arrest and apoptosis. Zhang XH; Liu YX; Jia M; Han JS; Zhao M; Ji SP; Li AM Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):29-36. PubMed ID: 25553351 [TBL] [Abstract][Full Text] [Related]
14. Oridonin represses lung cancer cell proliferation and migration by modulating AFAP1-AS1/IGF2BP1. Chen M; Shen Y Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):108-113. PubMed ID: 38836673 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
16. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects. Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686 [TBL] [Abstract][Full Text] [Related]
17. Oridonin inhibits BxPC-3 cell growth through cell apoptosis. Xu B; Shen W; Liu X; Zhang T; Ren J; Fan Y; Xu J Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):164-73. PubMed ID: 25651847 [TBL] [Abstract][Full Text] [Related]
18. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma. Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563 [TBL] [Abstract][Full Text] [Related]
19. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors. Wang YY; Lv YF; Lu L; Cai L Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795 [TBL] [Abstract][Full Text] [Related]
20. Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation. Lin TY; Hsu HY Cancer Lett; 2016 Jun; 375(2):340-348. PubMed ID: 26992741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]